Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Olema Pharmaceuticals Inc (NQ: OLMA ) 11.64 +0.12 (+1.00%) Streaming Delayed Price Updated: 1:09 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 113,402 Open 11.62 Bid (Size) 11.63 (8) Ask (Size) 11.67 (8) Prev. Close 11.53 Today's Range 11.58 - 11.94 52wk Range 8.510 - 17.79 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Olema Oncology Presents Compelling New Preclinical Data Demonstrating Anti-Tumor Activity for OP-3136 with Enhanced Activity of Palazestrant Combinations at ENA 2024 October 23, 2024 From Olema Oncology Via GlobeNewswire Why Intuitive Surgical Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket October 18, 2024 Via Benzinga Performance YTD -15.19% -15.19% 1 Month -5.33% -5.33% 3 Month -29.25% -29.25% 6 Month +15.64% +15.64% 1 Year -22.05% -22.05% More News Read More Olema Oncology Announces New Preclinical Combination Data to be Presented at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics October 09, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 02, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 04, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference August 21, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update August 06, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 02, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 02, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 04, 2024 From Olema Oncology Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Intraday Session June 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session June 03, 2024 Via Benzinga Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday June 03, 2024 Via Benzinga Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 03, 2024 Via Benzinga Olema Oncology to Participate in Upcoming Investor Conferences in June May 28, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress May 15, 2024 From Olema Oncology Via GlobeNewswire OLMA Stock Earnings: Olema Pharmaceuticals Misses EPS for Q1 2024 May 08, 2024 Via InvestorPlace Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update May 08, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress May 08, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 02, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology to Participate in Upcoming Investor Conferences in May May 01, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference April 08, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 02, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update March 11, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Announces Publication of Data Highlighting Palazestrant’s Ability to Inhibit Wild-Type and Mutant ER+ Breast Cancer Both as Monotherapy and in Combination with CDK4/6 Inhibitors March 06, 2024 From Olema Oncology Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
